B. Riley Financial, Inc. Spectrum Pharmaceuticals Inc Transaction History

B. Riley Financial, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$9.08 - $11.84 $230,268 - $300,262	-25,360 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$6.39 - $16.99 $3,980 - $10,584	623 Added 2.52%	25,360 $222,000
Q3 2018 Nov 13, 2018	BUY	$16.52 - $24.82 $89,571 - $134,574	5,422 Added 28.07%	24,737 $416,000
Q2 2018 Aug 15, 2018	SELL	$14.31 - $21.75 $4.06 Million - $6.17 Million	-283,600 Reduced 93.62%	19,315 $405,000
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $4.33 Million - $6.59 Million	302,915 New	302,915 $405,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of B. Riley Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on B. Riley Financial, Inc. with notifications on news.